Gaertner, F. A.
The nt lesion must involve tryptophan pyrrolase (tryptophan-2, 3-dioxygenase, EC 1.13.1.12). However, A response to a letter from David Perkins we still have no direct evidence that this is the case since tryptophan oxygenase has not been detected concerning the question of whether nt in N. crassa or for that matter in any other mold that we have tested: Mucor, Rhizopus, Aspergillus, mutants involve tryptophan pyrrolase.
Penicillium, and Saccharomyces (Gaertner and Salvoni, unpublished results). We have a very sensitive fluorometric assay (1973 Arch. Biochem. Biophys. 156: 658) that works well for liver, bacterial and Drosophila tryptophan oxygenases. Our initial report of success in assaying the enzyme in Neurospora crassa slime still holds. Unfortunately, however, this only amounts to a whole cell assay and so far has not been useful for wild type N. crassa. Hence, we have only been able to assay for the presence or absence of tryptophan oxygenase in nt mutants. The following story describes what we do know about nt mutants (unpublished data).
In an attempt to isolate mutants of 3-deoxy-D-arabinoheptulosanate 7-phosphate (DAHP) synthase (trp) in N. crassa , and to test the idea that DAHP for tryptophan synthesis is channeled via the aro multienzyme system, we treated conidia with nitrosoguanidine and carried out a filtration enrichment for a trp auxotroph in a medium containing high concentrations of Phe and Tyr (with the idea that the other two synthase isozymes would be inhibited). We then scored for trp auxotrophs that could grow also on quinic acid. The idea was that any trp auxotroph, that could not grow on minimal medium (in addition to no growth on minimal plus high concentrations, 400 µg/ml, of Phe and Tyr) but could grow on quinic acid, must have its lesion prior to dehydroquinic acid and should be a "channeling mutant" with a defective DAHP synthase (trp) isozyme. A long shot idea perhaps, and probably a very naive thing to try, but we were able to find such a mutant.
Its properties were the following. It was a non-leaky, it did not grow on Vogel's minimal. It was for all appearances a typical tryptophan auxotroph, responding well to the usual 20 to 40 µg/ml supplement of tryptophan. However it also grew well on Phe and on Tyr, but not at all when both Phe and Tyr were present, and it grew well on a 100 µg/ml supplement of quinic acid. Thus, we had it. A channeling mutant for the aro pathway! We then assayed for DAHP synthase (trp) expecting to find it inactive. To our surprise (and great disappointment) it had wild type levels of DAHP synthase (trp). After this, and for reasons which I no longer remember, we tried to grow the mutant on other amino acids (no response) and also tried niacin. This was all done before I knew anything of nt mutants.
To my surprise, niacin permitted growth even better than tryptophan. To make a long story short, our so called channeling mutant was none other than one of the old nt mutants, now called nt 295 (FGSC #2438 A and #2439 a). It is, perhaps, the only known example of a niacin auxotroph isolated by filtration enrichment. 
